Division of Cardiovascular Medicine, The University of Texas Medical School at Houston and The Memorial Hermann Heart and Vascular Institute, Houston, TX, USA.
J Thorac Cardiovasc Surg. 2010 Nov;140(5):1181-8. doi: 10.1016/j.jtcvs.2010.03.043. Epub 2010 May 23.
Controversy exists regarding the optimal pumping method for left ventricular assist devices. The purpose of this investigation was to test the hypothesis that pulsatile left ventricular assist synchronized to the cardiac cycle provides superior left ventricular unloading and circulatory support compared with continuous-flow left ventricular assist devices at the same level of ventricular assist device flow.
Seven male pigs were used to evaluate left ventricular assist device function using the TORVAD synchronized pulsatile-flow pump (Windmill Cardiovascular Systems, Inc, Austin, Tex) compared with the Bio-Medicus BPX-80 continuous-flow centrifugal pump (Medtronic, Inc, Minneapolis, Minn). Experiments were carried out under general anesthesia, and animals were instrumented via a median sternotomy. Hemodynamic measurements were obtained in the control state and with left ventricular assistance using the TORVAD and BPX-80 individually. Left ventricular failure was induced with suture ligation of the mid-left anterior descending coronary artery, and hemodynamic measurements were repeated.
During left ventricular assist device support, mean aortic pressure and total cardiac output were higher and left atrial pressure was lower with pulsatile compared with continuous flow at the same ventricular assist device flow rate. During ischemic left ventricular failure, pulsatile left ventricular support resulted in higher total cardiac output (5.58 ± 1.58 vs 5.12 ± 1.19, P < .05), higher mean aortic pressure (67.8 ± 14 vs 60.2 ± 10, P < .05), and lower left atrial pressure (11.5 ± 3.5 vs 13.9 ± 6.0, P < .05) compared with continuous flow at the same left ventricular assist device flow rate.
Synchronized, pulsatile left ventricular assistance produces superior left ventricular unloading and circulatory support compared with continuous-flow left ventricular assist at the same flow rates.
对于左心室辅助装置的最佳泵送方法存在争议。本研究的目的是检验这样一个假设,即与连续流左心室辅助装置相比,与心脏周期同步的脉动左心室辅助以相同的心室辅助装置流量提供更好的左心室卸载和循环支持。
使用 TORVAD 同步脉动流泵(Windmill Cardiovascular Systems,Inc.,Austin,Tex)比较与 Bio-Medicus BPX-80 连续流离心泵(Medtronic,Inc.,Minneapolis,Minn)的左心室辅助装置功能,使用 7 只雄性猪进行。在全身麻醉下进行实验,并通过正中胸骨切开术对动物进行仪器操作。在控制状态和单独使用 TORVAD 和 BPX-80 进行左心室辅助时,获得血流动力学测量值。通过左前降支中段缝线结扎诱导左心室衰竭,并重复血流动力学测量值。
在左心室辅助装置支持期间,与连续流相比,在相同的心室辅助装置流量下,脉动流的平均主动脉压和总心输出量更高,左心房压更低。在缺血性左心室衰竭期间,与连续流相比,脉动左心室支持导致更高的总心输出量(5.58±1.58 对 5.12±1.19,P<.05)、更高的平均主动脉压(67.8±14 对 60.2±10,P<.05)和更低的左心房压(11.5±3.5 对 13.9±6.0,P<.05)在相同的心室辅助装置流量下。
与连续流左心室辅助相比,同步脉动左心室辅助在相同流量下可产生更好的左心室卸载和循环支持。